Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.11% vs 5.02% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -30.11% vs 101.93% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 3.27% vs 3.26% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -26.94% vs 17.64% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Nanjing Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.11% vs 5.02% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -2.83% vs 2.11% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -30.11% vs 101.93% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.81% vs 9.50% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 3.27% vs 3.26% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -16.07% vs -0.02% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -26.94% vs 17.64% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -6.76% vs -21.73% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






